Comparison of VentiBroncTM Anchor With Conventional Double-lumen Endobronchial Tube in Patients With High Risk of Malposition
Launched by YONSEI UNIVERSITY · Sep 22, 2023
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is studying two different types of tubes used for a procedure called double-lumen endotracheal intubation, which is often needed during thoracic (chest) surgeries. The researchers want to find out if a newer tube called the VentiBronc™ Anchor, which has three cuffs, works better than the traditional double-lumen tube (Shiley®) for patients who are at a higher risk of the tube being misplaced. The goal is to see if the VentiBronc™ Anchor helps doctors successfully place the tube in the correct position, specifically in the left main bronchus, which is an important part of the airway.
To qualify for this trial, participants should be adults aged 20-85 who need a double-lumen tube for surgery and meet certain health criteria, including having a specific body size and airway measurements. Eligible participants can expect to be randomly assigned to receive either the VentiBronc™ Anchor or the conventional tube during their surgery. This study is currently recruiting, and it's open to all genders. If you're considering participating, it's a chance to help researchers learn more about improving intubation techniques for patients undergoing chest surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients requiring left double-lumen endotracheal tube intubation for thoracic surgery.
- • ASA physical status classification 2-4. Female patients aged 20-85 with a height of 160cm or less and a body mass index (BMI) of 25.0 kg/m2 or higher.
- • Patients requiring VentiBroncTM Anchor 33Fr or Shiley® 32Fr intubation due to a left mainstem bronchus diameter of 11mm or less on chest CT.
- Exclusion Criteria:
- • Intraluminal lesions in the left or right mainstem bronchi. History of airway surgery. Emergency surgery.
About Yonsei University
Yonsei University, a prestigious institution located in South Korea, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Yonsei University leverages its extensive expertise and innovative approaches in various fields of medicine to conduct rigorous clinical trials aimed at improving patient outcomes and advancing healthcare solutions. The university's robust infrastructure, multidisciplinary collaboration, and adherence to ethical standards ensure the integrity and reliability of its research initiatives, making it a key player in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Kyuho Lee
Principal Investigator
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported